The role of porphyrin chemistry in tumor imaging and photodynamic therapy

M Ethirajan, Y Chen, P Joshi, RK Pandey - Chemical Society Reviews, 2011 - pubs.rsc.org
In recent years several review articles and books have been published on the use of
porphyrin-based compounds in photodynamic therapy (PDT). This critical review is focused …

Pancreatic cancer

D Li, K Xie, R Wolff, JL Abbruzzese - The Lancet, 2004 - thelancet.com
Pancreatic cancer remains a major unsolved health problem, with conventional cancer
treatments having little impact on disease course. Almost all patients who have pancreatic …

A tabulated summary of the FDG PET literature

SS Gambhir, J Czernin, J Schwimmer… - Journal of nuclear …, 2001 - Soc Nuclear Med
This special supplement to The Journal of Nuclear Medicine is a detailed tabulation of
literature on FDG PET in oncology (1993–June 2000), cardiology (1986–June 2000), and …

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography …

SP Kauhanen, G Komar, MP Seppänen… - Annals of …, 2009 - journals.lww.com
Objective: To prospectively compare the accuracy of combined positron emission
tomography/computed tomography using 18 F-fluorodeoxyglucose (FDG-PET/CT) …

[HTML][HTML] Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010

C Sharma, KM Eltawil, PD Renfrew… - World journal of …, 2011 - ncbi.nlm.nih.gov
Several advances in genetics, diagnosis and palliation of pancreatic cancer (PC) have
occurred in the last decades. A multidisciplinary approach to this disease is therefore …

Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with pancreatic cancer

JW Lee, CM Kang, HJ Choi, WJ Lee… - Journal of nuclear …, 2014 - Soc Nuclear Med
In this study, we aimed to assess the prognostic value of metabolic tumor volume (MTV) and
total lesion glycolysis (TLG) measured on 18F-FDG PET/CT in pancreatic cancer patients …

Pancreatic cancer

TP Yeo, RH Hruban, SD Leach, RE Wilentz… - Current problems in …, 2002 - Elsevier
I n the United States there are 28,000 to 30,300 newly diagnosed cases of pancreatic cancer
and approximately an equal number of deaths per year from pancreatic cancer. 1, 2 Ductal …

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness

S Heinrich, GW Goerres, M Schäfer… - Annals of …, 2005 - journals.lww.com
Objective: We sought to determine the impact of positron emission tomography/computed
tomography (PET/CT) on the management of presumed resectable pancreatic cancer and to …

Positron Emission Tomography With [18F] Fluoro–2–Deoxy–D–Glucose for Diagnosis and Staging of Bile Duct Cancer

R Kluge, F Schmidt, K Caca, H Barthel, S Hesse… - Hepatology, 2001 - journals.lww.com
Malignant tumors with high glucose metabolic rates accumulate [18F]–fluorodeoxyglucose
(FDG), a positron emitting tracer. The aim of this study was to evaluate FDG positron …

Decreased blood flow with increased metabolic activity: a novel sign of pancreatic tumor aggressiveness

G Komar, S Kauhanen, K Liukko, M Seppänen… - Clinical Cancer …, 2009 - AACR
Purpose: To study blood flow (BF) and metabolism in normal pancreas and in different
pancreatic lesions. We then determined the effect of these biomarkers on outcome in …